237 related articles for article (PubMed ID: 29461655)
1. Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer.
Morisada M; Chamberlin M; Allen C
Head Neck; 2018 Jun; 40(6):1321-1334. PubMed ID: 29461655
[TBL] [Abstract][Full Text] [Related]
2. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.
Knitz MW; Bickett TE; Darragh LB; Oweida AJ; Bhatia S; Van Court B; Bhuvane S; Piper M; Gadwa J; Mueller AC; Nguyen D; Nangia V; Osborne DG; Bai X; Ferrara SE; Boss MK; Goodspeed A; Burchill MA; Tamburini BAJ; Chan ED; Pickering CR; Clambey ET; Karam SD
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883256
[TBL] [Abstract][Full Text] [Related]
3. [Immune checkpoint inhibitor therapy in advanced head and neck cancer].
Hang W; Xu ZX; Zhang Q; Lu X; Liu G
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 52(1):67-70. PubMed ID: 28104022
[TBL] [Abstract][Full Text] [Related]
4. Advances in Combining Radiation and Immunotherapy in Breast Cancer.
Nguyen AT; Shiao SL; McArthur HL
Clin Breast Cancer; 2021 Apr; 21(2):143-152. PubMed ID: 33810972
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II Pilot Study of Wilms' Tumor 1 Peptide-Pulsed Dendritic Cell Vaccination Combined With Conventional Chemotherapy in Patients With Head and Neck Cancer.
Ogasawara M; Miyashita M; Yamagishi Y; Ota S
Ther Apher Dial; 2019 Jun; 23(3):279-288. PubMed ID: 31033141
[TBL] [Abstract][Full Text] [Related]
6. Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade.
Heath BR; Michmerhuizen NL; Donnelly CR; Sansanaphongpricha K; Sun D; Brenner JC; Lei YL
J Dent Res; 2019 Sep; 98(10):1073-1080. PubMed ID: 31340724
[TBL] [Abstract][Full Text] [Related]
7.
De La Maza L; Wu M; Wu L; Yun H; Zhao Y; Cattral M; McCart A; Cho BJ; de Perrot M
Clin Cancer Res; 2017 Sep; 23(18):5502-5513. PubMed ID: 28606922
[No Abstract] [Full Text] [Related]
8. HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
Elbers JBW; Gunsch PA; Debets R; Keereweer S; van Meerten E; Zindler J; van Norden Y; Hoogeman MS; Verduijn GM; Kroesen M; Nout RA
BMC Cancer; 2023 Jun; 23(1):541. PubMed ID: 37312053
[TBL] [Abstract][Full Text] [Related]
9. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.
Hu ZI; Ho AY; McArthur HL
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):153-164. PubMed ID: 28816141
[TBL] [Abstract][Full Text] [Related]
10. The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review.
Ghanizada M; Jakobsen KK; Grønhøj C; von Buchwald C
Oral Oncol; 2019 Mar; 90():67-73. PubMed ID: 30846179
[TBL] [Abstract][Full Text] [Related]
11. PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation.
Morisada M; Clavijo PE; Moore E; Sun L; Chamberlin M; Van Waes C; Hodge JW; Mitchell JB; Friedman J; Allen CT
Oncoimmunology; 2018; 7(3):e1395996. PubMed ID: 29399393
[TBL] [Abstract][Full Text] [Related]
12. Is Locally Advanced Head-Neck Cancer One More Candidate for Accelerated Hypofractionation?
Koukourakis IM; Zygogianni A; Kouloulias V; Kyrgias G; Panteliadou M; Nanos C; Abatzoglou I; Koukourakis MI
Anticancer Res; 2021 Jan; 41(1):467-475. PubMed ID: 33419845
[TBL] [Abstract][Full Text] [Related]
13. Combining radiation therapy with immune checkpoint blockade for the treatment of small cell lung cancer.
Saxena A
Semin Cancer Biol; 2023 May; 90():45-56. PubMed ID: 36787870
[TBL] [Abstract][Full Text] [Related]
14. The biology of combination immunotherapy in recurrent metastatic head and neck cancer.
Yuan X; Yi M; Zhang W; Xu L; Chu Q; Luo S; Wu K
Int J Biochem Cell Biol; 2021 Jul; 136():106002. PubMed ID: 33962022
[TBL] [Abstract][Full Text] [Related]
15. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial.
Vreugdenhil M; Fong C; Sanghera P; Hartley A; Dunn J; Mehanna H
Oral Oncol; 2021 Feb; 113():105112. PubMed ID: 33321287
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
Lee L; Matulonis U
Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.
Leidner R; Crittenden M; Young K; Xiao H; Wu Y; Couey MA; Patel AA; Cheng AC; Watters AL; Bifulco C; Morris G; Rushforth L; Nemeth S; Urba WJ; Gough M; Bell RB
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963014
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunotherapy for the treatment of head and neck cancer.
Karam SD; Raben D
Lancet Oncol; 2019 Aug; 20(8):e404-e416. PubMed ID: 31364593
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response.
Alinezhad M; Bakhshandeh M; Rostami E; Alimohamadi R; Mosaffa N; Jalali SA
PLoS One; 2020; 15(4):e0231507. PubMed ID: 32287292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
